search
Back to results

Dementia Symptom Management at Home Program

Primary Purpose

Dementia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
DSM-H
Standard of Care
Sponsored by
NYU Langone Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dementia

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • PWD over the age of 65
  • Admitted to one of the three HHC agencies
  • The patient and family caregiver speak English and/or Spanish.
  • The informal caregiver is ≥18 years of age and spends at least 8 hours per week with the patient.
  • Patients who score ≥6 on the Quick Dementia Rating Scale (at least mild impairment).

Exclusion Criteria:

  • Patients with a separate Axis 1 diagnosis other than forms of dementia, depression or anxiety.
  • PWD residing in assisted living facilities or board and care homes
  • PWD solely receiving infusion or home health aide services.

Sites / Locations

  • New York University School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

QI program care

Control

Arm Description

DSM-H performance improvement program Patients in the performance improvement group will receive care from a care team who has received the DSM-H performance improvement program

provide usual carereceive usual care from a care team who has not received the performance improvement program

Outcomes

Primary Outcome Measures

Change in Quality of Life-Alzheimer's Disease Score
13-item measurement of Alzheimer's disease patients' health-related quality of life (HRQOL) by proxy (caregiver) assessment. Each item is rated on a 4-point Likert scale ranging from 1 (poor) to 4 (excellent). The total score is the sum of responses; higher scores indicate greater HRQOL. An increase in scores indicates HRQOL increased during the observational period.
Change in Caregiver-Targeted Quality of Life Measure Score
The Caregiver-Targeted Quality of Life (CG-QOL) measure covers 10 dimensions of QOL relevant to caregivers of persons with dementia. The CG-QOL comprises 80 items distributed across 10 scales: assistance with ADLs, assistance with IADLs, personal time, role limitation due to caregiving, family involvement, demands of caregiving, worry, caregiver feelings, spirituality and faith, benefits of caregiving. The total score ranges from 0-100; higher scores indicate greater quality of life. An increase in scores indicates quality of life improved over the observational period.
Number of ER Visits by Patients with Dementia (PWD) during Study Period
Measured through interviews with the informal caregiver using the Resource Utilization Inventory.
Number of PWD Inpatient Admissions during Study Period
Measured through interviews with the informal caregiver using the Resource Utilization Inventory.

Secondary Outcome Measures

Change in Pain Assessment In Advanced Dementia (PAINAD) Score
5-item assessment of pain in individuals with advanced dementia. Items are ranked on a 3-point Likert scale from 0 to 2. The total score is the sum of responses and ranges from 0 (no pain) to 10 (severe pain). An increase in scores indicates pain increased during the observational period.
Change in Neuropsychiatric Inventory Questionnaire (NPI-Q) Score
13-item tool that measures caregiver perceptions of Behavioral and Psychological Symptoms of Dementia (BPSD). For each item, The severity of the reported symptoms is assessed on a 3-point scale. The total severity score ranges from 0 to 36 with higher scores representing worse severity. An increase in score indicates severity of BPSD increased during the observational period.
Number of PWD who Use Antipsychotics during Study Period
Measured via patient medication record.
Number of PWD who Use Analgesics during Study Period
Measured via patient medication record.
Number of PWD Outpatient Visits during Study Period
Number of PWD Primary Care Provider Contacts during Study Period
Change in Zarit Burden Inventory Score among Caregivers
22-item self-assessment of burden experienced by caregivers. Items are ranked on a Likert scale from 0 (never) to 4 (nearly always). The total score is the sum of responses and ranges from 0 to 88, where: 0 - 21 = little or no burden; 21 - 40 = mild to moderate burden; 41 - 60 = moderate to severe burden; and 61 - 88 = severe burden. An increase in scores indicates burden increased during the observational period.
Change in Public Health Questionnaire-9 (PHQ-9) Score among Caregivers
9-item measurement of depression in which caregivers indicate how often they have been bothered by specific problems over the previous 2 weeks. Items are ranked on 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The total score is the sum of responses and ranges from 0 to 27; higher scores indicate greater severity of depression.
Change in Short-Form-12 (SF-12) Score among Caregivers
12-item tool that measures functional health and well-being. Two summary scores are reported from the SF-12 - a mental component score (MCS-12) and a physical component score (PCS-12). Physical and Mental Health Composite Scores (PCS & MCS) are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.

Full Information

First Posted
August 15, 2017
Last Updated
December 5, 2022
Sponsor
NYU Langone Health
search

1. Study Identification

Unique Protocol Identification Number
NCT03255967
Brief Title
Dementia Symptom Management at Home Program
Official Title
A Multisite Cluster RCT of the Dementia Symptom Management at Home Program
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
August 16, 2018 (Actual)
Primary Completion Date
March 31, 2022 (Actual)
Study Completion Date
May 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NYU Langone Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Alzheimer's Disease and Related Disorders (dementia) poses a significant challenge to our public health. While many persons with dementia are cared for by friends and family in the community with the assistance of home healthcare, most home healthcare clinicians and agencies are ill prepared to care for this population and therefore have difficulty assisting patients and caregivers in maintaining quality of life leading to adverse patient outcomes, increased caregiver stress and burnout, and healthcare utilization. This study will therefore utilize a cluster randomized controlled design at 3 study sites to examine the ability of a multi-component evidence-based practice primary palliative care quality improvement program for home healthcare registered nurses, occupational therapists and physical therapists to improve the quality of life and reduce healthcare utilization for persons with dementia and their informal caregiver.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dementia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
217 (Actual)

8. Arms, Groups, and Interventions

Arm Title
QI program care
Arm Type
Experimental
Arm Description
DSM-H performance improvement program Patients in the performance improvement group will receive care from a care team who has received the DSM-H performance improvement program
Arm Title
Control
Arm Type
Active Comparator
Arm Description
provide usual carereceive usual care from a care team who has not received the performance improvement program
Intervention Type
Behavioral
Intervention Name(s)
DSM-H
Intervention Description
Multi-modal quality improvement program for improving the quality of care provided to PWD-informal caregiver dyads through HHC
Intervention Type
Behavioral
Intervention Name(s)
Standard of Care
Intervention Description
Subjects receive care through usual home healthcare assignment process.
Primary Outcome Measure Information:
Title
Change in Quality of Life-Alzheimer's Disease Score
Description
13-item measurement of Alzheimer's disease patients' health-related quality of life (HRQOL) by proxy (caregiver) assessment. Each item is rated on a 4-point Likert scale ranging from 1 (poor) to 4 (excellent). The total score is the sum of responses; higher scores indicate greater HRQOL. An increase in scores indicates HRQOL increased during the observational period.
Time Frame
Baseline, Day 60
Title
Change in Caregiver-Targeted Quality of Life Measure Score
Description
The Caregiver-Targeted Quality of Life (CG-QOL) measure covers 10 dimensions of QOL relevant to caregivers of persons with dementia. The CG-QOL comprises 80 items distributed across 10 scales: assistance with ADLs, assistance with IADLs, personal time, role limitation due to caregiving, family involvement, demands of caregiving, worry, caregiver feelings, spirituality and faith, benefits of caregiving. The total score ranges from 0-100; higher scores indicate greater quality of life. An increase in scores indicates quality of life improved over the observational period.
Time Frame
Baseline, Day 60
Title
Number of ER Visits by Patients with Dementia (PWD) during Study Period
Description
Measured through interviews with the informal caregiver using the Resource Utilization Inventory.
Time Frame
Up to Day 60
Title
Number of PWD Inpatient Admissions during Study Period
Description
Measured through interviews with the informal caregiver using the Resource Utilization Inventory.
Time Frame
Up to Day 60
Secondary Outcome Measure Information:
Title
Change in Pain Assessment In Advanced Dementia (PAINAD) Score
Description
5-item assessment of pain in individuals with advanced dementia. Items are ranked on a 3-point Likert scale from 0 to 2. The total score is the sum of responses and ranges from 0 (no pain) to 10 (severe pain). An increase in scores indicates pain increased during the observational period.
Time Frame
Baseline, Day 60
Title
Change in Neuropsychiatric Inventory Questionnaire (NPI-Q) Score
Description
13-item tool that measures caregiver perceptions of Behavioral and Psychological Symptoms of Dementia (BPSD). For each item, The severity of the reported symptoms is assessed on a 3-point scale. The total severity score ranges from 0 to 36 with higher scores representing worse severity. An increase in score indicates severity of BPSD increased during the observational period.
Time Frame
Baseline, Day 60
Title
Number of PWD who Use Antipsychotics during Study Period
Description
Measured via patient medication record.
Time Frame
Up to Day 60
Title
Number of PWD who Use Analgesics during Study Period
Description
Measured via patient medication record.
Time Frame
Up to Day 60
Title
Number of PWD Outpatient Visits during Study Period
Time Frame
Up to Day 60
Title
Number of PWD Primary Care Provider Contacts during Study Period
Time Frame
Up to Day 60
Title
Change in Zarit Burden Inventory Score among Caregivers
Description
22-item self-assessment of burden experienced by caregivers. Items are ranked on a Likert scale from 0 (never) to 4 (nearly always). The total score is the sum of responses and ranges from 0 to 88, where: 0 - 21 = little or no burden; 21 - 40 = mild to moderate burden; 41 - 60 = moderate to severe burden; and 61 - 88 = severe burden. An increase in scores indicates burden increased during the observational period.
Time Frame
Baseline, Day 60
Title
Change in Public Health Questionnaire-9 (PHQ-9) Score among Caregivers
Description
9-item measurement of depression in which caregivers indicate how often they have been bothered by specific problems over the previous 2 weeks. Items are ranked on 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The total score is the sum of responses and ranges from 0 to 27; higher scores indicate greater severity of depression.
Time Frame
Baseline, Day 60
Title
Change in Short-Form-12 (SF-12) Score among Caregivers
Description
12-item tool that measures functional health and well-being. Two summary scores are reported from the SF-12 - a mental component score (MCS-12) and a physical component score (PCS-12). Physical and Mental Health Composite Scores (PCS & MCS) are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.
Time Frame
Baseline, Day 60

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: PWD over the age of 65 Admitted to one of the three HHC agencies The patient and family caregiver speak English and/or Spanish. The informal caregiver is ≥18 years of age and spends at least 8 hours per week with the patient. Patients who score ≥6 on the Quick Dementia Rating Scale (at least mild impairment). Exclusion Criteria: Patients with a separate Axis 1 diagnosis other than forms of dementia, depression or anxiety. PWD residing in assisted living facilities or board and care homes PWD solely receiving infusion or home health aide services.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Abraham Brody, MD
Organizational Affiliation
NYU Langone Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
New York University School of Medicine
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
32320844
Citation
Bristol AA, Convery KA, Sotelo V, Schneider CE, Lin SY, Fletcher J, Rupper R, Galvin JE, Brody AA. Protocol for an embedded pragmatic clinical trial to test the effectiveness of Aliviado Dementia Care in improving quality of life for persons living with dementia and their informal caregivers. Contemp Clin Trials. 2020 Jun;93:106005. doi: 10.1016/j.cct.2020.106005. Epub 2020 Apr 19.
Results Reference
derived

Learn more about this trial

Dementia Symptom Management at Home Program

We'll reach out to this number within 24 hrs